Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up

被引:94
作者
Aakhus, S [1 ]
Dahl, K
Wideroe, TE
机构
[1] Rikshosp Univ Hosp, Dept Cardiol, N-0026 Oslo, Norway
[2] Univ Trondheim Hosp, Dept Med, Nephrol Sect, N-7006 Trondheim, Norway
关键词
cardiovascular diseases; diabetes mellitus; ischemic heart disease; kidney transplantation; mortality; risk factors;
D O I
10.1111/j.1399-0012.2004.00235.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Although cardiovascular disease is a major cause of death after renal transplantation (Tx), predictors for cardiovascular events have not been well defined. Aims of this cross-sectional study were first to assess cardiovascular morbidity and mortality in stable renal Tx patients, and to identify predictors for cardiovascular events during long-term follow-up. Methods: In all, 406 renal Tx patients (mean age: 47 yr, 60.1% males, 70.9% using cyclosporine A) commenced a baseline registration (median) 48 months after Tx, and 405 was thereafter followed in 5 yr. Kaplan-Meier plots and multivariate regression analysis (Cox proportional hazards model) were used to identify and characterize predictors for cardiovascular events. Results: There were 88 deaths (average annual mortality: 4.4%), and 74% of these were cardiovascular. In age groups 40-49, 50-59, and 60-69 yr, odds ratio for cardiovascular mortality in patients vs. general population was 46.2, 20.1, and 8.0, respectively. Death from ischemic heart disease (IHD) was independently predicted by baseline congestive heart failure (relative risk: RR 5.33), diabetes (RR 2.28), systolic blood pressure (mmHg, RR 1.02), age (yr, RR 1.06), and high-density lipoprotein cholesterol (mmol/L, RR 0.36). Predictors for a major ischemic heart event (death from or onset of IHD) were in addition baseline total cholesterol (mmol/L, RR 1.18) and cerebrovascular disease (RR 2.98). Conclusions: Thus, IHD was the major cause of death late after renal Tx, and a major ischemic heart event was predicted by baseline congestive heart failure, diabetes, age, hypertension, and hypercholesterolemia.
引用
收藏
页码:596 / 604
页数:9
相关论文
共 29 条
[1]   Hyperlipidaemia in renal transplant patients [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (05) :407-415
[2]   Cardiovascular morbidity and risk factors in renal transplant patients [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) :648-654
[3]  
Altman DG, 1990, PRACTICAL STAT MED R
[4]   THE PREVALENCE OF HYPERLIPIDEMIA IN RENAL-TRANSPLANT RECIPIENTS - ASSOCIATIONS WITH IMMUNOSUPPRESSIVE AND ANTIHYPERTENSIVE THERAPY [J].
BITTAR, AE ;
RATCLIFFE, PJ ;
RICHARDSON, AJ ;
RAINE, AEG ;
JONES, L ;
YUDKIN, PL ;
CARTER, R ;
MANN, JI ;
MORRIS, PJ .
TRANSPLANTATION, 1990, 50 (06) :987-992
[5]   RENAL REPLACEMENT THERAPY IN PATIENTS WITH DIABETIC NEPHROPATHY, 1980-1985 [J].
BRUNNER, FP ;
BRYNGER, H ;
CHALLAH, S ;
FASSBINDER, W ;
GEERLINGS, W ;
SELWOOD, NH ;
TUFVESON, G ;
WING, AJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1988, 3 (05) :585-595
[6]   HYPERTENSION AFTER RENAL-TRANSPLANTATION - A COMPARISON OF CYCLOSPORINE AND CONVENTIONAL IMMUNOSUPPRESSION [J].
CHAPMAN, JR ;
MARCEN, R ;
ARIAS, M ;
RAINE, AEG ;
DUNNILL, MS ;
MORRIS, PJ .
TRANSPLANTATION, 1987, 43 (06) :860-864
[7]   MULTIVARIATE SURVIVAL ANALYSIS USING COX REGRESSION-MODEL [J].
CHRISTENSEN, E .
HEPATOLOGY, 1987, 7 (06) :1346-1358
[8]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[9]   Patient survival after renal transplantation: II. The impact of smoking [J].
Cosio, FG ;
Falkenhain, ME ;
Pesavento, TE ;
Yim, S ;
Alamir, A ;
Henry, ML ;
Ferguson, RM .
CLINICAL TRANSPLANTATION, 1999, 13 (04) :336-341
[10]   LONG-TERM CARDIOVASCULAR MORBIDITY AND MORTALITY IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE PATIENTS AFTER RENAL-TRANSPLANTATION [J].
FLORIJN, KW ;
CHANG, PC ;
VANDERWOUDE, FJ ;
VANBOCKEL, JH ;
VANSAASE, JLCM .
TRANSPLANTATION, 1994, 57 (01) :73-81